Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Benznidazole Evaluation for Interrupting Trypanosomiasis - The BENEFIT Trial

NCT00123916 is registered in ClinicalTrials.gov with Population Health Research Institute as lead sponsor.

NCT NCT00123916
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00123916 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Benznidazole Evaluation for Interrupting Trypanosomiasis - The BENEFIT Trial
Lead sponsor
Population Health Research Institute
Phase
Phase 3
Overall status
Completed
Start date
November 30, 2004
Completion date
August 31, 2015
Enrollment
2,854 (actual)
Sites
47

Conditions

As the registry lists them; a condition with its own page is linked.

chagas disease, heart disease, trypanosomiasis